Individualized carbohydrate-reduced nutritional therapy

Individualized carbohydrate-reduced nutritional therapy is associated with body weight in humans (Adjusted weight loss: 30.7 versus 24.1 lb; observed weight loss: 13.3% versus 11.1%).

“Among GLP-1-naive semaglutide users, adjusted 12-month weight loss was greater with VINT+IOM than IOM only (30.7 vs. 24.1 lb; P=0.01)”

HumansGLP-1-naive semaglutide users; individualized nutritional therapy plus medication versus medication-based care without structured nutritional therapy12 months

Real-World Twelve-Month Weight Loss Outcomes in a Comprehensive Obesity Care Program Utilizing Individualized Nutrition Therapy and Incretin-Based Obesity Medications

medRxiv·13 Oct 2026Preprint